These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3618541)

  • 1. Aminothiadiazole (NSC #4728) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group.
    Asbury RF; Blessing JA; Mortel R; Homesley HD; Malfetano J
    Am J Clin Oncol; 1987 Aug; 10(4):299-301. PubMed ID: 3618541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminothiadiazole (NSC 4728) in patients with advanced nonsquamous carcinoma of the cervix. A phase II study of the Gynecologic Oncology Group.
    Asbury RF; Blessing JA; DiSaia PJ; Malfetano J
    Am J Clin Oncol; 1989 Oct; 12(5):375-7. PubMed ID: 2801597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminothiadiazole (NSC 4728) in patients with advanced carcinoma of the endometrium. A phase II study of the Gynecologic Oncology group.
    Asbury RF; Blessing JA; McGuire WP; Hanjani P; Mortel R
    Am J Clin Oncol; 1990 Feb; 13(1):39-41. PubMed ID: 2407103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminothiadiazole (NSC 4728) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group.
    Asbury RF; Wilson J; Blessing JA; Buchsbaum HJ; DiSaia PJ
    Am J Clin Oncol; 1986 Aug; 9(4):334-6. PubMed ID: 3751971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trail of aminothiadiazole in patients with mixed mesodermal tumors of the uterine corpus: a Gynecologic Oncology Group study.
    Asbury R; Blessing JA; Moore D
    Am J Clin Oncol; 1996 Aug; 19(4):400-2. PubMed ID: 8677914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminothiadiazole (NSC #4728) in patients with advanced colon cancer. A phase II study of the Eastern Cooperative Oncology Group.
    Asbury RF; Kramar A; Haller DG
    Am J Clin Oncol; 1987 Oct; 10(5):380-2. PubMed ID: 3661489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of aminothiadiazole in advanced squamous cell carcinoma of the esophagus.
    Engstrom PF; Ryan LM; Falkson G; Haller DG
    Am J Clin Oncol; 1991 Feb; 14(1):33-5. PubMed ID: 1987735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial of gallium nitrate (NSC #15200) in advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Malfetano JH; Blessing JA; Homesley HD; Hanjani P
    Invest New Drugs; 1991 Feb; 9(1):109-11. PubMed ID: 2026479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminothiadiazole in the treatment of advanced leiomyosarcoma of the uterine corpus. A Gynecologic Oncology Group study.
    Asbury R; Blessing JA; Smith DM; Carson LF
    Am J Clin Oncol; 1995 Oct; 18(5):397-9. PubMed ID: 7572755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: a Gynecologic Oncology Group study.
    Jacobs AJ; Blessing JA; Munoz A
    Gynecol Oncol; 1992 Mar; 44(3):268-70. PubMed ID: 1541440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of fazarabine (NSC 281272) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Manetta A; Blessing JA; Mann WJ; Smith DM
    Am J Clin Oncol; 1995 Oct; 18(5):439-40. PubMed ID: 7572764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG).
    Muss HB; Blessing JA; Eddy GL; McGehee R
    Invest New Drugs; 1992 Apr; 10(1):25-6. PubMed ID: 1607251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone (NSC 301739) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group.
    Muss HB; Sutton GP; Bundy B; Hatch KD
    Am J Clin Oncol; 1985 Aug; 8(4):312-5. PubMed ID: 3909803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced squamous cancer of the cervix. A Gynecologic Oncology Group study.
    McGuire WP; Blessing JA; Hatch KD; Berman ML
    Invest New Drugs; 1990 May; 8(2):195-7. PubMed ID: 2384306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose aminothiadiazole in advanced colorectal cancer. An Illinois Cancer Center phase II trial.
    Locker GY; Kilton L; Khandekar JD; Lad TE; Knop RH; Albain K; Blough R; French S; Benson AB
    Invest New Drugs; 1994; 12(4):299-301. PubMed ID: 7775130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Malfetano J
    Am J Clin Oncol; 1990 Jun; 13(3):191-3. PubMed ID: 2346124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial of didemnin B (NSC #335319) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
    Malfetano JH; Blessing JA; Homesley HD; Look KY; McGehee R
    Am J Clin Oncol; 1996 Apr; 19(2):184-6. PubMed ID: 8610646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Gynecologic Oncology Group phase II study of amonafide (NSC #308847) in squamous cell carcinoma of the cervix.
    Asbury RF; Blessing JA; Soper JT
    Am J Clin Oncol; 1994 Apr; 17(2):125-8. PubMed ID: 8141104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of galactitol 1,2:5,6-dianhydro (NSC 132313) in the treatment of advanced gynecologic malignancies: a Gynecologic Oncology Group study.
    Stehman FB; Blom J; Blessing JA; Ehrlich CE; Mangan C
    Gynecol Oncol; 1983 Jun; 15(3):381-90. PubMed ID: 6862293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Muderspach LI; Blessing JA; Levenback C; Moore JL
    Gynecol Oncol; 2001 May; 81(2):213-5. PubMed ID: 11354055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.